335 filings
Page 2 of 17
8-K
ab9 sezeab4f6bksu
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
8-K/A
zaw6p ibzyw9u4txl6xk
22 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K
bz55c
9 Aug 23
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:10am
8-K
035e5u jj8c
30 Jun 23
Departure of Directors or Certain Officers
4:50pm
8-K
k9zxu6
27 Jun 23
Departure of Directors or Certain Officers
4:46pm
8-K/A
i34 9zu23f1
14 Jun 23
Departure of Directors or Certain Officers
4:35pm
S-8
yqwm2boxxy975wy
9 Jun 23
Registration of securities for employees
5:19pm
8-K
wgzs6yd
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
qcnu1 ygnx7n7cn
5 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
t91f2d3t7tgwvp
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
424B5
d88jemq copprfvwco
25 May 23
Prospectus supplement for primary offering
12:29pm
424B5
fc8r6s7
25 May 23
Prospectus supplement for primary offering
12:27pm
424B5
i6yu2ob w03rwnwtx
25 May 23
Prospectus supplement for primary offering
12:25pm
424B4
5v09fru5w5ok2ksqr4xt
24 May 23
Prospectus supplement with pricing info
4:05pm
EFFECT
310qaf lkz
23 May 23
Notice of effectiveness
12:15am
CORRESP
h9q2 64zu
19 May 23
Correspondence with SEC
12:00am
CORRESP
mb0ug
19 May 23
Correspondence with SEC
12:00am
8-K
7fdrdtj161yu z6ku1t
17 May 23
Other Events
7:30am